Daniel Drucker

@danieljdrucker.bsky.social

A clinician scientist at LTRI @sinaihealth studying Glucagon, GIP, GLP-1, GLP-2, diabetes, obesity, metabolism and the gut endocrine system

Honored to share that Dr. Gökhan Hotamışlıgil has been elected to the National Academy of Sciences, one of the highest distinctions in science recognizing outstanding, sustained contributions to research. Huge congratulations to Dr. Hotamışlıgil on this remarkable and well-deserved honor!

National Academy of Sciences Elects Members and International Members - NAS

WASHINGTON — The National Academy of Sciences announced today the election of 120 members and 25 international members in recognition of their distinguished and continuing achievements in original res...

nasonline.org

Could Ozempic be the solution to inflammatory diseases? Perhaps not for all of them, but compelling research from @danieljdrucker.bsky.social's lab and others is exploring where GLP-1s' anti-inflammatory properties could have meaningful clinical benefits. My latest @sciam.bsky.social

Ozempic’s greatest benefit may be their anti-inflammatory power

A growing body of research suggests that GLP-1 drugs do more than control appetite and blood sugar. They could also fight inflammation

scientificamerican.com